Canagliflozin versus placebo for post-bariatric surgery patients with persistent type II diabetes: A randomized controlled trial (CARAT). (Q48135951)
Jump to navigation
Jump to search
scientific article published on 20 December 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Canagliflozin versus placebo for post-bariatric surgery patients with persistent type II diabetes: A randomized controlled trial (CARAT). |
scientific article published on 20 December 2016 |
Statements
Canagliflozin versus placebo for post-bariatric surgery patients with persistent type II diabetes: A randomized controlled trial (CARAT) (English)
Sangeeta R Kashyap
9 February 2017
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference